Madrigal Pharmaceuticals
MDGL
MDGL
136 hedge funds and large institutions have $1.01B invested in Madrigal Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-20
Holders Change %
-12.82%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
22
Increased
52
Reduced
46
Closed
42
Calls
$96.1M
Puts
$17M
Net Calls
+$79.1M
Net Calls Change
+$2.42M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
$77.7M |
| 2 |
JPMorgan Chase & Co
New York
|
$44M |
| 3 |
State Street
Boston,
Massachusetts
|
$67.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
$34.5M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
$9.45M |
